PuSH - Publikationsserver des Helmholtz Zentrums München

8 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Lutter, J. et al.: Treatment of COPD Groups GOLD A and B with inhaled corticosteroids in the COSYCONET cohort - determinants and consequences. Int. J. Chron. Obstruct. Pulmon. Dis. 16, 987-998 (2021)
2.
Stöber, A. et al.: Impact of lung function and exacerbations on health-related quality of life in copd patients within one year: Real-world analysis based on claims data. Int. J. Chron. Obstruct. Pulmon. Dis. 16, 2637-2651 (2021)
3.
Lutter, J. et al.: Impact of education on COPD severity and all-cause mortality in lifetime never-smokers and longtime ex-smokers: Results of the COSYCONET cohort. Int. J. Chron. Obstruct. Pulmon. Dis. 15, 2787-2798 (2020)
4.
Byng, D. et al.: Determinants of healthcare utilization and costs in COPD patients: First longitudinal results from the German COPD cohort COSYCONET. Int. J. Chron. Obstruct. Pulmon. Dis. 14, 1423-1439 (2019)
5.
Pedersen, F.* et al.: Rating sputum cell quality in clinical trials for asthma and COPD treatment. Int. J. Chron. Obstruct. Pulmon. Dis. 14, 195-198 (2019)
6.
Alter, P.* ; Rabe, K.F.* ; Schulz, H. ; Vogelmeier, C.F.* & Joerres, R.A.*: Influence of body mass on predicted values of static hyperinflation in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 13, 2551-2555 (2018)
7.
Wacker, M. et al.: The contribution of symptoms and comorbidities to the economic impact of COPD: An analysis of the German COSYCONET cohort. Int. J. Chron. Obstruct. Pulmon. Dis. 12, 3437-3448 (2017)
8.
Karrasch, S. et al.: What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study. Int. J. Chron. Obstruct. Pulmon. Dis. 11, 1881-1894 (2016)